Answers are grounded in this paper and cite their sources.
Demonstrates protective effects of phosvitin phosphopeptides in neuroblastoma cells, suggesting potential therapeutic applications.
The antioxidant and protective effects of phosvitin phosphopeptides (PPPs) in human neuroblastoma were studied. Phosvitin from chicken egg yolk was pretreated using high-temperature mild pressure (HTMP) conditions and then hydrolyzed using trypsin (T), Multifect 14L (M), and trypsin + Multifect 14L (TM) to prepare 4 PPPs treatments (HTMP, HTMP-T, HTMP-M, and HTMP-TM). The antioxidant and protective properties of PPPs were assessed using chemical analyses and human neuroblastoma (SH-SY-5Y) cells. All PPPs exhibited reducing power and radical scavenging, metal-chelating, β-carotene bleaching inhibitory, and lipid peroxidation inhibitory activities, but HTMP-TM had the highest antioxidant activity. HTMP-TM increased cell viability and reduced reactive oxygen species production and apoptosis in stressed (H2O2-treated) SH-SY-5Y cells. Additionally, HTMP-TM downregulated B-cell lymphoma-2 (Bcl-2)-associated X protein/Bcl-2 and caspase-3 expression but upregulated catalase expression in oxidatively stressed SH-SY-5Y cells. It was concluded that HTMP-TM exerted protective effects through their antioxidative and anti-apoptotic properties in oxidatively stressed SH-SY-5Y cells.
No takes yet. Share an insight, caveat, or question.
Lee et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: